1. Home
  2. ARAY

as 11-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Founded: 1990 Country:
United States
United States
Employees: N/A City: MADISON
Market Cap: 171.0M IPO Year: 2007
Target Price: $9.00 AVG Volume (30 days): 646.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $1.40 - $3.05 Next Earning Date: 11-06-2024
Revenue: $444,204,000 Revenue Growth: -2.37%
Revenue Growth (this year): 6.33% Revenue Growth (next year): 5.60%

ARAY Daily Stock ML Predictions

Stock Insider Trading Activity of Accuray Incorporated (ARAY)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Pervaiz Ali ARAY SVP Chief Financial Officer Sep 4 '24 Sell $2.06 8,404 $17,276.10 394,138

Share on Social Networks: